A Practical Guide to Biopharma Year-End Planning
As summer winds down and vacations (sadly) come to an end, it’s a natural time…
Building Credibility as a New Leader
Credibility is essential for leaders in any industry, but in the high-stakes…
BIO and Boston: The Global Stage and HLYB
Attending a large conference, medical congress, or trade show can be both…
Season of Transitions
Three notable transitions worthy of reflection at this point in time.
Your Biopharma Data Needs a Strategy
In the not-so-distant past, physician prescribing data was essentially a commodity with limited breadth or depth for the purposes of drug development…
Success in Rare Disease: Patient Involvement Matters!
This past December, the FDA finalized its guidance on rare diseases with the publication Rare Diseases: Considerations for the Development of Drugs…
Juggling Geographic Commercialization Priorities
Commercializing a pharmaceutical asset in one country is hard enough. Doing it on a global scale, with multiple country differences, is exponentially…
Happy Anniversary to Us!
I grew up in the Midwest — the middle child in a large family. We were each tagged with certain labels and expectations: the smart ones, the…
Hybrid Work Strategies: 3 Tips to Transform Engagement
In this post-COVID era, our clients have experienced a culture shift — driven by remote work, digital transformation, accelerated innovation, and a…
Medical Affairs: An Orchestra, Not a Horse Race
Every horse race has a starting bell, a push to move as fast as possible, and a finish line. In many ways, the launch of a new drug can feel similar.…
Three Big Mistakes
Over the past 20 years, The NemetzGroup has been involved in the launch of more than 50 different drugs and has had input into the strategic…
What’s the Latest?
There are many ways we introduce ourselves to make an impact and grab the attention of our audience. In our line of work, that might be what your…
Gen Z Advice for Seasoned Boomers
“Gen Z professionals have a low tolerance for inefficiency and are not going to allow their boomer bosses to remain selective luddites.” That’s how…
The Truth about Teams
When it comes to team performance and adherence to “best practices,” what works on paper or in a teambuilding workshop and what actually occurs are…